Automated peptide mapping and protein-topographical annotation of proteomics data by Pavankumar Videm et al.
Videm et al. BMC Bioinformatics 2014, 15:207
http://www.biomedcentral.com/1471-2105/15/207SOFTWARE Open AccessAutomated peptide mapping and protein-
topographical annotation of proteomics data
Pavankumar Videm1,2†, Deepika Gunasekaran1†, Bernd Schröder3, Bettina Mayer1, Martin L Biniossek1
and Oliver Schilling1,4,5*Abstract
Background: In quantitative proteomics, peptide mapping is a valuable approach to combine positional quantitative
information with topographical and domain information of proteins. Quantitative proteomic analysis of cell surface
shedding is an exemplary application area of this approach.
Results: We developed ImproViser (www.improviser.uni-freiburg.de) for fully automated peptide mapping of
quantitative proteomics data in the protXML data. The tool generates sortable and graphically annotated output,
which can be easily shared with further users. As an exemplary application, we show its usage in the proteomic
analysis of regulated intramembrane proteolysis.
Conclusion: ImproViser is the first tool to enable automated peptide mapping of the widely-used protXML format.
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Peptide mapping is increasingly recognized as a valuable
tool in quantitative proteomics. It integrates quantitative
information of individual, typically tryptic, peptides with
topographical protein annotation such as individual
domains. Manual peptide mapping has established that
matrix metalloprotease (MMP)-2 proteolytically releases
the chemokine fractalkine into the pericellular milieu [1].
Peptide mapping is also crucial for correct functional
annotation, e.g. distinguishing collagen cleavage products
with signaling function from the actual collagen protein
with a predominantly structural role [2].
Signal-peptide-peptidase-like (SPPL) proteases SPPL2a
and –b cleave transmembrane proteins within the lipid
bilayer with a preference for transmembrane proteins in
type 2 orientation [3]. The few annotated substrates of
SPPL2a and -b include tumor necrosis factor [4,5], the
Fas ligand [6] and the invariant chain (CD74) of the
major histocompatibility class II complex [7-10]. Common* Correspondence: oliver.schilling@mol-med.uni-freiburg.de
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unless otherwise stated.features of SPPL2a/b substrates include a short cytoplasmic
tail and a large ectodomain. SPPL proteases release the
cytoplasmic tail after initial shedding of the ectodomain by
other proteases. From a proteomic perspective, quantitative
alterations of the cytoplasmic tail are typically oversha-
dowed by peptides stemming from the ectodomain. This
makes peptide mapping useful in the proteomic analysis of
SPPL proteolysis.
Some proteomic applications already include peptide
mapping. A strategy termed PROTOMAP combines high
coverage peptide mapping with size shift analysis to
detect proteolytic truncation of proteins [11]. A novel tool
termed QARIP [12] works with the proteomic software
Maxquant [13] to analyze cell surface shedding by auto-
mated peptide mapping. Similarly, the PROTTER tool
integrates experimental proteomics data with protein
sequence annotations [14].
protXML is a well-established format to report protein
identification and quantitation based on liquid chromatog-
raphy–tandem mass spectrometry (LC–MS/MS). protXML
is most prominently implemented by the Trans Proteomic
Pipeline (TPP) [15], a set of open–source tools for quanti-
tative proteomic data analysis. A large user community
extensively employs the TPP which is known for supporting
a large range of data formats and mass spectrometers [16].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2105/15/207Since the TPP continues to be a widespread tool, we
aimed to develop a web–based service for fully automated
peptide mapping analysis from quantitative protXML data
together with protein topographical annotation. Our aims
included:
1. Deconvolute global protein ratios by spatially
resolving the underlying peptide ratios.
2. Facilitate the analysis of cell surface shedding by
distinguishing extra- and intracellular ratios for
membrane–spanning proteins.
3. Facilitate interpretation of proteomic results by
linking protein IDs to the corresponding UniProt
information [17].
4. Share these results with non–expert users and
collaborators in a straightforward manner.Figure 1 Flowchart depicting the working procedure of the ImproVis
retrieved from this file, it refers to the UniProt database to obtain selected
generates a graphical table with all relevant information. This output is theTo fulfill these requirements, we developed ImproViser
(Improved Visualizer of protXML data), which is freely
accessible at www.improviser.uni-freiburg.de.
Implementation
ImproViser is a web-based platform implemented in Perl.
It reads user–provided protXML data, which has been
generated by ProteinProphet [18] as part of the TPP pack-
age [15]. ImproViser interacts with the UniProt database
to obtain protein annotation. A compressed output file
is generated for local storage and sharing. ImproViser
output can be visualized using web-browsers with CSS3
support., i.e. Firefox. The workflow is shown in Figure 1.
ImproViser supports protein identifications originating
from sequence databases that adhere to UniProt [17] or
International Protein Index (IPI) nomenclature [19]. Theer tool. The tool accepts a protXML file as input. Using information
information and delivers it back to the ImproViser script, which
n compressed and can be downloaded as a zip file by the user.
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http://www.biomedcentral.com/1471-2105/15/207tool obtains UniProt identifiers from the protXML file
and subsequently retrieves the following entry-specific
information from the UniProt database: recommended
name; molecular weight; length; topological information
such as presence and location of transmembrane regions,
N-terminal signal peptides, cytoplasmic, and extra-cyto-
plasmic (e.g. extracellular, and luminal) domains.
By default, ImproViser rejects protein entries with a
ProteinProphet probability score < 0.90 [18]. This value
is user − adjustable. ImproViser further extracts the
relative quantitation as represented by the “light to
heavy (L:H) ratio” derived by stable isotope labeling in
a typical quantitative proteomics experiment. The TPP
includes two software tools for relative quantitation:
ASAPRatio [20] and XPRESS [21], with ASAPRatio being
a more advanced approach for protein and peptide quanti-
tation. ImproViser reports ASAPRatio. The tool offers the
possibility to validate ASAPRatio quantitation by XPRESS
quantitation if such values are included in the protXML
file. Such a validation strategy has been of use in some
recent quantitative proteomic studies [2,22], especially
since ASAPratio occasionally displays inaccuracies with
regard to background removal and separation of neighbor-
ing peaks [23]. L:H ratios are log2 transformed. Further
input options are described in Table 1.
Protein entries are considered as being “valid” if they
pass the criteria described above. For each valid protein
entry, ImproViser retrieves annotation from UniProt as
described above. In addition, the tool extracts the indi-
vidual peptide L:H ratios (as determined by ASAPRatio)
for each valid protein entry. Peptide ratios are normalized
as described above, log2 transformed, and graphically
mapped on the linear protein sequence using a red − greenTable 1 User-adjustable options
Option Variable name Default value Description
Invert H and L -insert off This function en
heavy to light r
Validate ASAPratio
with Xpress
-validate off This function va
results with XPR
Elaborate list of peptides -elaborate off Selecting this fu
identified more
Prophet probab
ProteinProphet cutoff -threshold 0.90 This function en
Any protein wit
Minimum peptide ratio -rmin -3.0 This function en
the peptide. Th
Maximum peptide ratio -rmax 3.0 This function en
the peptide. Th
Negative no change zone -zn -0.25 This function en
peptide. i.e. the
Positive no change zone -zp 0.25 This function en
peptide. i.e. thescale to visualize individual peptide ratios. For protein re-
gions that are explicitly annotated as being cytoplasmic
or extra-cytoplasmic, ImproViser calculates a novel
average ratio.
ImproViser is accessible via www.improviser.uni-frei-
burg.de. A test data set is also available for download. The
user uploads an input protXML file and the tool generates
an output HTML file (named index.html), which enables
a tabulated visualization of the input. The tool outlines
the details of the identified proteins and peptides. It
also enables the user to select proteins based on specific
features such as presence of N-terminal signal peptides
and presence of transmembrane regions. The tool further
generates (a) a log file which contains a list of proteins
that were discarded (named run_stats.out), (b) a .txt file
containing the information about the average molecular
weight of the proteins listed in the output HTML file
(named average_molecular_weight.txt), (c) a .txt file
describing the system requirements and browser compati-
bility for viewing the output HTML file in its intended
format (named suppoted_browsers_and_os.txt), (d) folders
for storing images which are displayed in the index.html
file (named images, small_images), and (e) a folder for
storing HTML file link for specific proteins (named
index_files). ImproViser also copies the necessary java
scripts and css files required for the script to generate
the formatted output. The formatted output produced
by the tool is supported by all css3 compatible web
browsers. The above-mentioned files are compressed in
a zip format and presented for download. In our experi-
ence, the file size is often below 10 MB, thus allowing
for easy sharing with collaborators via e-mail or file
transfer services.ables the user to invert the light to heavy ratios in the ProtXML file to
atios.
lidates the ASAPRatio [8] (Automated Statistical Analysis on Protein Ratio)
ESS [9] results.
nction displays the list of all occurrences of a peptide (in case they are
than once, by default the tool chooses the peptide with highest Peptide
ility score).
ables the user to set the cutoff for the ProteinProphet probability score.
h a score less than this cutoff is discarded.
ables the user to set the minimum value allowed for light:heavy ratio of
is measure is then used for scaling of the peptide ratios.
ables the user to set the maximum value allowed for light:heavy ratio of
is measure is then used for scaling of the peptide ratios.
ables the user to set the negative threshold for light to heavy ratio of the
peptide ratios between the Zn and Zp thresholds are categorized together.
ables the user to set the positive threshold for light to heavy ratio of the
peptide ratios between the Zn and Zp thresholds are categorized together.
Table 2 Proteomic analysis of the murine BMDC
membrane fraction
Total proteins identified and quantified 1231
– with annotated transmembrane domain 629
– with annotated signal peptide sequence
and with signal peptide sequence
171
– with annotated transmembrane domain
but without signal peptide sequence
458
– with annotated transmembrane domain and
quantified peptides of cytoplasmic localization
385
– with annotated transmembrane domain and
quantified peptides of extra-cytoplasmic localization
362
Figure 2 Screenshot of output HTML file (index.html) generated by ImproViser using a the data set reported in this manuscript.
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General
A screenshot of an exemplary analysis is depicted in
Figure 2. The different analysis options are described in
Table 1. The performance of the ImproViser tool was
investigated using the test data set. The size of the
ProtXML test data was approximately 2.5 Mb (containing
625 proteins). The time taken for output generation was
approximately 4 min. The size of the compressed output
file was approximately 5 Mb.
Application to proteomic analysis of SPPL −mediated
intramembrane proteolysis
As outlined above, SPPL2a and SPPL2b typically cleave
type 2 transmembrane proteins with short cytoplasmic
tails following the initial proteolytic shedding of a larger
ectodomain. For proteomic analysis of putative SPPL2a/b
substrates, bone marrow derived dendritic cells (BMDCs)
were prepared from mice deficient for both SPPL2a and
SPPL2b (SPPL2a-/- SPPL2b-/-). Control BMDCs were
generated from bone marrow of wild-type mice. BMDC
isolation and culture has been performed as described
previously [7]. Subsequently, cells were harvested and
mechanically disrupted. Total cellular membranes were
recovered by ultracentrifugation from a post-nuclear
supernatant and washed with 100 mM sodium carbonate,
pH 11.5, in order to enrich integral membrane proteins as
described previously [24]. Following tryptic digestion
in the presence of the acid labile surfactant RapiGest
(Waters), peptides were dimethylated with stable isotopic
forms of formaldehyde as described previously [2,22]. LC-
MS/MS and corresponding data analysis with the TPP
were also performed as described previously [2,22]. The
resulting prot.xml file was further analyzed by ImproViser.
The proteomic analysis of the membrane-enriched
fraction from wild-type and SPPL2a-/- SPPL2b-/- BMDCs
identified and quantified a total of 1231 proteins (Table 2).
Of these, 629 (51%) featured a transmembrane domain as
annotated by Uniprot. The large proportion of membrane
spanning proteins indicates successful enrichment mem-
brane proteins from the BMDCs. To a large extent (73%),
Uniprot did not report a signal peptide sequence for the
membrane spanning proteins.
Overall, the fold-change (Fc) values (log2 of light to
heavy ratios) for all identified proteins followed a nearnormal distribution with most proteins displaying none
or very little quantitative alteration (Figure 3a). A similar
near-normal Fc-value distribution is also observed for
membrane-spanning proteins with regard to their global
Fc-values (Figure 3b) as well as Fc-values based on pep-
tides stemming from cytoplasmic or extra-cytoplasmic
protein regions (Figure 3c,d). These data underline that
deletion of SPPL2a and -2b does not result in major
perturbations of the BMDC membrane proteome.
We hypothesized that lack of SPPL2a and -2b activity
leads to an accumulation of N-terminal fragments of
putative SPPL substrates in the BMDC membrane fraction,
as compared to the corresponding wild-type cells. Based
on our knowledge of currently recognized SPPL2a/b
substrates (see Introduction), further criteria for SPPL
substrates are classification as a type 2 transmembrane
protein with a single membrane spanning domain to-
gether with the presence of an extended ectodomain and
a short cytoplasmic tail. To identify putative substrates of
SPPL2a and -2b, we focused on proteins that adhere to
this topology. Further selection criteria were a more than
2-fold accumulation (Fc-value > 1) of the cytoplasmic tail.
Three proteins match these criteria: tumor necrosis factor,
invariant chain (CD74) of the major histocompatibility
class II complex, and macrophage receptor MARCO.
Of these, tumor necrosis factor, invariant chain (CD74)
of the major histocompatibility class II complex represent
established SPPL substrates, thus validating our approach
(Figure 4).
For the invariant chain (CD74) of the major histocom-
patibility class II complex, opposing quantitative alter-
ations are found for the cytoplasmic tail and ectodomain:
Figure 4 Peptide mapping for known substrates of SPPL2a and -2b, as determined by the proteomic analysis of a murine BMDC
membrane fraction comparing wild-type cells to SPPL2a-/- SPPL2b-/- cells.
Figure 3 Distribution of fold-change values (log2 of light: heavy ratios) for the proteomic analysis of a murine BMDC membrane fraction
comparing wild-type cells to SPPL2a-/- SPPL2b-/- cells. (a) all identified proteins, (b) membrane-spanning proteins, (c) cytoplasmic domains of
membrane-spanning proteins, (d) non-cytoplasmic domains of membrane-spanning proteins (e.g. extracellular, lumenal).
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ectodomain shows decreased levels (Figure 4). Due to its
larger size, multiple peptides stem from the ectodomain
as opposed to a single cytoplasmic peptide which spans
most of the cytoplasmic tail. Without accurate protein
topological annotation, accumulation of the cytoplasmic
tail would be overshadowed by more numerous ectodo-
main peptides with opposing Fc-values. This example
further illustrates the usefulness of peptide mapping in
functional annotation of quantitative proteomics data.
It is an intrinsic feature of every peptide mapping
approach that quantitations of protein domains are based
on less peptide features than those for the entire protein.
For example, the cytoplasmic tail of the invariant chain
(CD74) of the major histocompatibility class II complex
encompasses 29 amino acids with one tryptic peptide
of 17 residues. The reduced number of peptide features
employed in domain quantitation necessitates particular
care in the interpretation of such results since individual
peptide quantitations are prone to poor chromatographic
resolution [23] or non-dynamic behaviour in quantitative
proteomic analysis [25].Conclusion
Peptide mapping is a useful additional level of proteomic
data analysis. The ImproViser tool serves as a platform to
automate this process and provides a graphical represen-
tation of protXML data, as highlighted by an exemplary
proteomic analysis of regulated intramembrane proteolysis.
We consider quantitative proteomic analysis of cell surface
shedding to be a major application area of ImproViser. It
might also be of interest for the proteomic analysis of other
post-translational modifications such as phosphorylation.Availability and requirements
Project name: ImproViser
Project home page: www.improviser.uni-freiburg.de
Operating system: Platform independent
Programming language: Perl
Other requirements: Requires web browsers that support
css3, hence recent versions of Firefox, Chrome and Opera
are recommended.
License: ImproViser is available freely online at www.
improviser.uni-freiburg.de
Any restrictions to use by non-academics: none
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